Balloon pulmonary angioplasty for occlusive lesions of pulmonary artery in Takayasu arteritis: A cohort study
Therapeutic Advances in Respiratory Disease · 2026
DOI: 10.1177/17534666261492547 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2026. Verfasst von Xin Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pulmonary Vascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking U…. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Takayasu Arteritis, Pulmonary Artery, Stenosis, Pulmonary Artery. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, National Key Research and Development Program of China Stem Cell and Translational Research, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Background
Occlusive pulmonary arterial lesions represent a major technical challenge for balloon pulmonary angioplasty (BPA) in patients with Takayasu arteritis–associated pulmonary artery involvement. However, evidence and procedural guidance regarding BPA for occlusive lesions in this population remain limited.
Objectives
This study aimed to summarize our center experience with BPA for occlusive pulmonary arterial lesions in patients with Takayasu arteritis and to identify potential risk factors associated with restenosis after BPA.
Design
Retrospective cohort.
Methods
We retrospectively enrolled patients with Takayasu arteritis who had occlusive pulmonary arterial lesions. Lesions were morphologically categorized as subtotal or total occlusions. Total occlusions were further subclassified as cone-shaped, pouch-like, or ostial occlusions.
Results
We included 66 patients with Takayasu arteritis, in whom 182 occlusive lesions were identified. In terms of locations, most ostial occlusions (56.52%) located lobar, while other kinds of lesions more common located segmentally. Total occlusions more frequently required guide-extension catheter support than subtotal occlusions (70.21% vs. 40.63%, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Pulmonary Vascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Xin Li, Huiyi Liu, Changming Xiong, Zhihong Liu
Förderung
- National High Level Hospital Clinical Research Funding
- National Key Research and Development Program of China Stem Cell and Translational Research
- China Postdoctoral Science Foundation
- Natural Science Foundation of Beijing Municipality
- Beijing Natural Science Foundation
- Chinese Academy of Medical Sciences
- CAMS Innovation Fund for Medical Sciences
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Li, X., Yang, T., Luo, Q., Zhao, Q., Huang, Z., Duan, A., Wang, Y., Gao, L., Li, S., Wang, Q., Xiang, J., Liu, H., Xiong, C., Zhao, Z., & Liu, Z. (2026). Balloon pulmonary angioplasty for occlusive lesions of pulmonary artery in Takayasu arteritis: A cohort study. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666261492547
Vancouver
Li X, Yang T, Luo Q, Zhao Q, Huang Z, Duan A, et al. Balloon pulmonary angioplasty for occlusive lesions of pulmonary artery in Takayasu arteritis: A cohort study. Therapeutic Advances in Respiratory Disease. 2026. doi:10.1177/17534666261492547
BibTeX
@article{Li2026,
author = {Li, Xin and Yang, Tao and Luo, Qin and Zhao, Qing and Huang, Zhihua and Duan, Anqi and Wang, Yijia and Gao, Luyang and Li, Sicong and Wang, Qi and Xiang, Jingjing and Liu, Huiyi and Xiong, Changming and Zhao, Zhihui and Liu, Zhihong},
title = {Balloon pulmonary angioplasty for occlusive lesions of pulmonary artery in Takayasu arteritis: A cohort study},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
doi = {10.1177/17534666261492547}
}
EUVIMED